This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
In the news release, Bernstein Liebhard LLP Announces Investigation Into Abiomed, Inc., issued
02-Nov-2012 by Bernstein Liebhard LLP over PR Newswire, we are advised by the company that a legal disclaimer has been added to the end of the release. The complete, corrected release follows:
Bernstein Liebhard LLP Announces Investigation Into Abiomed, Inc.
Nov. 2, 2012Bernstein Liebhard LLP today announced an investigation into Abiomed, Inc. (NASDAQ: ABMD) ("Abiomed" or the "Company") relating to the Company's marketing and labeling of its Impella 2.5 heart pump. Abiomed is a purported pioneer in healthcare technology and innovation and is famous for the world's first total replacement heart and the world's smallest heart pump. The Impella 2.5 pump is designed to provide short-term circulatory support for heart patients.